Products
Haemair was founded to develop an enhanced Extracorporeal Life Support (ECLS/ECMO) system to support patients with reversible life threatening respiratory or cardiac disease for periods days to weeks. We sought the best components for complete systems including oxygenators, pumps, and instruments. The technology has underpinned a portfolio of products with applications ranging from organ transplantation to blood transfusion.
About
Haemair was founded by engineers with close relatives who had suffered and died of lung disease. From the outset, the vision was of a device that would directly oxygenate blood to augment residual lung capacity and ultimately provide an alternative to lung transplant. In developing components for an improved system, the innovations have found a much wider range of applications.
News
US patent granted for a cell washing apparatus to improve blood transfusions
Publication of study showing that Haemair cell-washing apparatus removes potentially harmful components that accumulate during storage of transfusion blood without damaging red blood cells.
Use of Haemair pulsatile pump for ex-vivo perfusion of porcine kidneys shows improved urine production and reduced resistance to blood flow through compared to use of well-established centrifugal blood pump.